Michelle Lazzaro
Overview
Explore the profile of Michelle Lazzaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhanja A, Seeley-Fallen M, Lazzaro M, Upadhyaya A, Song W
Elife
. 2023 Dec;
12.
PMID: 38085658
Antigen-induced B-cell receptor (BCR) signaling is critical for initiating and regulating B-cell activation. The actin cytoskeleton plays essential roles in BCR signaling. Upon encountering cell-surface antigens, actin-driven B-cell spreading amplifies...
2.
Bhanja A, Seeley-Fallen M, Lazzaro M, Upadhyaya A, Song W
bioRxiv
. 2023 Mar;
PMID: 36993351
Antigen-induced B-cell receptor (BCR) signaling is critical for initiating and regulating B-cell activation. The actin cytoskeleton plays essential roles in BCR signaling. Upon encountering cell-surface antigens, actin-driven B-cell spreading amplifies...
3.
Seeley-Fallen M, Lazzaro M, Liu C, Li Q, Upadhyaya A, Song W
Front Immunol
. 2022 May;
13:842605.
PMID: 35493485
Antigen (Ag)-triggered B-cell receptor (BCR) signaling initiates antibody responses. However, prolonged or uncontrolled BCR signaling is associated with the development of self-reactive B-cells and autoimmune diseases. We previously showed that...
4.
Allen K, Cann J, Zhao W, Peterson N, Lazzaro M, Zhong H, et al.
PLoS One
. 2021 May;
16(5):e0252060.
PMID: 33999954
[This corrects the article DOI: 10.1371/journal.pone.0234268.].
5.
Allen K, Cann J, Zhao W, Peterson N, Lazzaro M, Zhong H, et al.
PLoS One
. 2020 Jun;
15(6):e0234268.
PMID: 32497150
Annexin A1 (anxA1) is an immunomodulatory protein that has been proposed as a tumor vascular target for antitumor biologic agents, yet to date the vascular expression of anxA1 in specific...
6.
Schneider-Ohrum K, Snell Bennett A, Rajani G, Hostetler L, Maynard S, Lazzaro M, et al.
J Virol
. 2019 May;
93(15).
PMID: 31092578
Respiratory syncytial virus (RSV) infection of seronegative children previously immunized with formalin-inactivated (FI) RSV has been associated with serious enhanced respiratory disease (ERD). The phenomenon was reproduced in the cotton...
7.
Cayatte C, Snell Bennett A, Rajani G, Hostetler L, Maynard S, Lazzaro M, et al.
PLoS One
. 2017 Nov;
12(11):e0188708.
PMID: 29182682
Respiratory syncytial virus (RSV) is recognized as an important cause of lower and upper respiratory tract infections in older adults, and a successful vaccine would substantially lower morbidity and mortality...
8.
Gartland A, Li S, McNevin J, Tomaras G, Gottardo R, Janes H, et al.
J Virol
. 2014 May;
88(15):8242-55.
PMID: 24829343
Unlabelled: The RV144 HIV-1 vaccine trial demonstrated partial efficacy of 31% against HIV-1 infection. Studies into possible correlates of protection found that antibodies specific to the V1 and V2 (V1/V2)...
9.
Heipertz Jr R, Sanders-Buell E, Kijak G, Howell S, Lazzaro M, Jagodzinski L, et al.
AIDS Res Hum Retroviruses
. 2013 Aug;
29(10):1310-20.
PMID: 23972100
The U.S. military represents a unique population within the human immunodeficiency virus 1 (HIV-1) pandemic. The last comprehensive study of HIV-1 in members of the U.S. Navy and Marine Corps...
10.
Rolland M, Edlefsen P, Larsen B, Tovanabutra S, Sanders-Buell E, Hertz T, et al.
Nature
. 2012 Sep;
490(7420):417-20.
PMID: 22960785
The RV144 trial demonstrated 31% vaccine efficacy at preventing human immunodeficiency virus (HIV)-1 infection. Antibodies against the HIV-1 envelope variable loops 1 and 2 (Env V1 and V2) correlated inversely...